Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-033004

Senior VP - Drug Discovery bought 25,000 shares at $1.45 ($36,250)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Babu Yarlagadda S Senior VP - Drug Discovery 2019-11-18 Purchase +25,000 $1.45 $36,250 155,587 D
Open-market purchases · 25,000 sh · avg $1.45 · $36,250
Loading xslF345X03/form4.xml…